Long-term efficacy of fractional microneedle radiofrequency versus botulinum toxin-A in primary axillary hyperhidrosis: a randomized controlled trial
Lasers in Medical Science · 2024
DOI: 10.1007/s10103-024-04115-x ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Medical Science, 2024. Verfasst von Reem O Eid und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, 11956, Egypt. Hauptthemen laut MEDLINE: Hyperhidrosis, Botulinum Toxins, Type A, Axilla, Patient Satisfaction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.
Abstract (Originalsprache)
Primary axillary hyperhidrosis is an idiopathic disorder that creates severe psycho-social burden due to excessive uncontrolled sweating. Various therapeutic agents have been described, but each has its own limitations. The use of fractional microneedling radiofrequency has emerged lately with promising results. This study aimed to determine the efficacy and safety of fractional microneedle radiofrequency in comparison to Botulinum toxin-A (BT-A) in patients with primary axillary hyperhidrosis. In this randomized controlled clinical trial, 20 patients (40 sides) were randomized to either fractional microneedle radiofrequency (4 sessions at 3-week intervals) or BT-A (single session), where each side received one of the treatment modalities. Efficacy was measured at 3, 6 and 12 months using Minor’s starch iodine test, HDSS score, Hqol questionnaire, and patient satisfaction. Fractional microneedle radiofrequency, although showed moderate efficacy, is inferior to BT-A regarding longitudinal efficacy at 12 months, as well as patients’ satisfaction. Both treatment modalities showed to be equally safe, but fractional microneedle radiofrequency procedure was substantially more painful. In conclusion, fractional microneedle radiofrequency does not offer a better substitute to BT-A in primary axillary hyperhidrosis. BT-A shows higher efficacy, is less painful, less expensive, and needs a smaller number of sessions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, 11956, Egypt.
- Department of Dermatology, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, 11956, Egypt. vanessahafez@kasralainy.edu.eg.
Förderung
- Cairo University
Zitieren
APA
Eid, R. O., Shaarawi, E., Hegazy, R. A., & Hafez, V. (2024). Long-term efficacy of fractional microneedle radiofrequency versus botulinum toxin-A in primary axillary hyperhidrosis: a randomized controlled trial. Lasers in Medical Science. https://doi.org/10.1007/s10103-024-04115-x
Vancouver
Eid RO, Shaarawi E, Hegazy RA, Hafez V. Long-term efficacy of fractional microneedle radiofrequency versus botulinum toxin-A in primary axillary hyperhidrosis: a randomized controlled trial. Lasers in Medical Science. 2024. doi:10.1007/s10103-024-04115-x
BibTeX
@article{Eid2024,
author = {Eid, Reem O and Shaarawi, Eman and Hegazy, Rehab A and Hafez, Vanessa},
title = {Long-term efficacy of fractional microneedle radiofrequency versus botulinum toxin-A in primary axillary hyperhidrosis: a randomized controlled trial},
journal = {Lasers in Medical Science},
year = {2024},
doi = {10.1007/s10103-024-04115-x}
}
EUVIMED